Publications by authors named "James J Java"

Claim this Profile
W
What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer.
Omali Pitiyarachchi, Michael Friedlander, James J Java, John K Chan, Deborah K Armstrong

Gynecol Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and preliminary results of an Electronic Medical Record (EMR)-integrated smartphone telemedicine program to deliver asthma care remotely.
Jennifer R Mammen, James J Java, Jill Halterman, Marc N Berliant, Amber Crowley

J Telemed Telecare· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients.
Katherine C Fuh, James J Java, John K Chan, Daniel S Kapp, Bradley J Monk

Gynecol Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixed-methods content and sentiment analysis of adolescents' voice diaries describing daily experiences with asthma and self-management decision-making.
Jennifer R Mammen, James J Java, Hyekyun Rhee, Arlene M Butz, Jill S Halterman

Clin Exp Allergy· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma.
Peter G Rose, James J Java, Ritu Salani, Melissa A Geller, Angeles Alvarez Secord

Obstet Gynecol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study" [Gynecol. Oncol. 151 (2018) 18-23].
Alexander B Olawaiye, James J Java, Thomas C Krivak, Michael Friedlander, David G Mutch

Gynecol Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study.
Alexander B Olawaiye, James J Java, Thomas C Krivak, Michael Friedlander, David G Mutch

Gynecol Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and Physician Perceptions of Virtual Visits for Parkinson's Disease: A Qualitative Study.
Jennifer R Mammen, Molly J Elson, James J Java, Christopher A Beck, Denise B Beran

Telemed J E Health· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study.
Erin A Bishop, James J Java, Kathleen N Moore, Nick M Spirtos, Michael L Pearl

Am J Obstet Gynecol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study.
Neil S Horowitz, G Larry Maxwell, Austin Miller, Chad A Hamilton, Bunja Rungruang, James J Java

Gynecol Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study.
Leigh G Seamon, James J Java, Bradley J Monk, Richard T Penson, Jubilee Brown

Br J Cancer· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologic and Treatment Outcomes Among a Geriatric Population of Endometrial Cancer Patients: An NRG Oncology/Gynecologic Oncology Group Ancillary Data Analysis of LAP2.
Erin A Bishop, James J Java, Kathleen N Moore, Joan L Walker

Int J Gynecol Cancer· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Peter G Rose, James J Java, Mark A Morgan, Angeles Alvarez-Secord, Joshua P Kesterson

Gynecol Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study.
Arlene E Garcia-Soto, James J Java, Wilberto Nieves Neira, J Matthew Pearson, David E Cohn

Gynecol Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients - An analysis of NRG Oncology/Gynecologic Oncology Group trials.
John K Chan, James J Java, Katherine Fuh, Bradley J Monk, Daniel S Kapp

Gynecol Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis.
Kathleen N Moore, James J Java, Katrina N Slaughter, Peter G Rose, Rachelle Lanciano

Gynecol Oncol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an NRG oncology/gynecologic oncology group study (ADS-1236).
Linda R Duska, James J Java, David E Cohn, Robert A Burger

Gynecol Oncol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: an NRG Oncology/GOG study.
James S Ferriss, James J Java, Michael A Bookman, Gini F Fleming, Bradley J Monk

Gynecol Oncol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival advantage and prognostic factors associated with intraperitoneal chemotherapy treatment in advanced ovarian cancer: a gynecologic oncology group study.
Devansu Tewari, James J Java, Ritu Salani, Deborah K Armstrong, Maurie Markman

J Clin Oncol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in gynecologic oncology group trials of cisplatin-based chemoradiation.
Peter G Rose, James J Java, Charles W Whitney, Frederick B Stehman, Rachelle Lanciano

Gynecol Oncol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy-induced neutropenia as a biomarker of survival in advanced ovarian carcinoma: an exploratory study of the gynecologic oncology group.
Krishnansu S Tewari, James J Java, Troy A Gatcliffe, Michael A Bookman, Bradley J Monk

Gynecol Oncol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the arm-wise false discovery rate in array comparative genomic hybridization experiments.
Daniel P Gaile, Elizabeth D Schifano, Jeffrey C Miecznikowski, James J Java, Jeffrey M Conroy

Stat Appl Genet Mol Biol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis